Corporate diversification allows for well-hidden financial ties between
pharmaceutical and tobacco companies, which can cause a conflict of interest
in the development and marketing of pharmaceutical products. In our investigation
of tobacco company documents released and posted on the Internet as a result
of the Master Settlement Agreement, we have found that these financial ties
have fostered both competition and collaboration between the tobacco and pharmaceutical
industries. We present 3 case studies. One shows how tobacco companies pressured
pharmaceutical companies to scale back their smoking cessation educational
materials that accompanied Nicorette. The second shows how they restricted
to whom the pharmaceutical company could market its transdermal nicotine patch.
In the third case, we show how subsidiary tobacco and pharmaceutical companies
of a parent company collaborated in the production of a nicotine-release gum.
Thus, because tobacco cessation product marketing has been altered as a result
of these financial conflicts, disclosure would serve the interest of public
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 19
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.